The Best Defense Against Breast Cancer is Early Detection: Honoring Breast Cancer Awareness Month

October 16, 2018
Category: iNFORMED - Blog

Founded in 1985, National Breast Cancer Awareness Month (BCAM) is celebrated each October with a mission of educating the public about the causes, risks, prevention and detection of breast cancer. With one in eight women developing invasive breast cancer over the course of her lifetime and more than 330,000 new cases being diagnosed every year, it has never been more important to bring attention to breast health. Interestingly, BCAM often assists in lifting the fear of the unknown about breast cancer and opens the door for many frank conversations about the... Continue reading

Tags: 3D Mammography Breast Cancer Detection
Honoring_Breast_Cancer_Awareness_Month.jpg

iCAD Announces Exceptional Study Results Demonstrating Significant Advantages of Revolutionary Artificial Intelligence Technology for Digital Breast Tomosynthesis

October 11, 2018
Category: Press Releases

Results demonstrate unprecedented improvements in clinical performance and reading times, validating the substantial benefits of artificial intelligence when used with 3D mammography


Company to showcase latest innovations in cancer detection at The European Society of Breast Imaging annual meeting in booth 14


NASHUA, N.H. and ATHENS, Greece, (October 11, 2018) – iCAD, Inc. (NASD... Continue reading

SUNY Upstate Medical University Selects iCAD’s Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

October 09, 2018
Category: Press Releases

Premier center becomes first in the region to offer intraoperative radiation therapy with the leading-edge Xoft System to advance quality patient care in New York State

 

NASHUA, N.H. and Syracuse, N.Y., (October 9, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is now available at Upstate Medical University. Affiliated w... Continue reading

Sanford Health Announces Adoption of iCAD’s Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

October 03, 2018
Category: Press Releases

Medical facility becomes first in South Dakota to offer intraoperative radiation therapy with the revolutionary Xoft System to improve patient care

 

NASHUA, N.H. and SIOUX FALLS, S.D., (October 3, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the availability of the company’s Xoft® Axxent®Electronic Brachytherapy (eBx®) System® at Sanford USD Medical Center. The new tr... Continue reading

Independent, Long-Term Study Highlights Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

October 01, 2018
Category: Press Releases

Retrospective trial utilizing intraoperative radiation therapy with the revolutionary Xoft System shows recurrence rates to be comparable to cornerstone TARGIT-A Trial at mean follow-up 4.6 years

 

NASHUA, N.H., (October 1, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the results of a long-term, independent study conducted with the Xoft® Axxent® Electronic Brachytherap... Continue reading

iCAD Announces AERB Approval of Xoft System in India

August 29, 2018
Category: Press Releases

First installation of versatile, multi-platform Xoft System in India demonstrates strong, continued momentum in global commercialization of electronic brachytherapy (eBx)

 

Nashua, N.H. and Hyderabad, India, (August 29, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® has received an Atomic Energy Regulatory Bo... Continue reading

Medical City Plano, a HCA Healthcare Facility, Adopts iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Breast Cancer

August 28, 2018
Category: Press Releases

Leading center becomes first in Texas to offer intraoperative radiation therapy with the advanced Xoft System to enhance patient care


NASHUA, N.H. and Plano, Texas, (August 28, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is now available at Medical City Plano. Operated by HCA Healthcare, the world-class medical facility in Plano, Texas is the first in the state to offer intraoper... Continue reading

iCAD Reports Second Quarter 2018 Financial Results

August 14, 2018
Category: Press Releases

PowerLook Tomo Detection Version 2.0 Submitted for FDA Approval


Conference call today at 4:30 p.m. ET


NASHUA, N.H. (August 14, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology

company providing innovative cancer detection and therapy solutions, today reported financial results for the three and six months ended June 30, 2018.


Second Quarter 2018 Highlights:

Total revenue of .2 million, down 4% year-over-year
Gross profit of .8 million, or 78%
GAAP Net Loss of (.0) million, or (
.06) per share
Non-GAAP Adju... Continue reading

iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis

August 08, 2018
Category: Press Releases

Breast Density Assessment Software Built on Artificial Intelligence

 

Nashua, NH – August 8, 2018 – iCAD (Nasdaq: ICAD), a global leader in medical technology providing innovative cancer detection and therapy solutions, announced today FDA clearance of its latest Artificial Intelligence software solution; PowerLook Density Assessment Version 3.4. The software is compatible with iCAD’s digital breast tomosynthesis (DBT) platform on both GE and Hologic systems, enhancing the Company’s comprehensive... Continue reading

iCAD To Report Second Quarter and Six Months Ended June 30, 2018 Financial Results On Tuesday, August 14TH

August 07, 2018
Category: Press Releases

NASHUA, N.H. (August 7, 2018) –  iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that it will release financial results for the second quarter and six months ended June 30, 2018 after the close of the market, and host a conference call at 4:30pm Eastern Time, on Tuesday, August 14th.

 

Tuesday, August 14th @ 4:30pm Eastern Time

Domest... Continue reading

3 Steps to Improve Your Overall Breast Health

July 25, 2018
Category: iNFORMED - Blog

We’re halfway through 2018, providing us with the perfect opportunity to reflect on the goals we have set for ourselves this year and how we are tracking toward them. At iCAD, our goal is to keep you iNFORMED and aware by sharing tips and resources that are pertinent to your breast health.


And while many individuals set goals and resolutions for themselves each year related to health, there are often other sides of health that get left behind – such as your breast health.


This year alone, an estimated 266,120 new cases of invasive breast cancer are exp... Continue reading

Tags: 3D Mammography Breast Cancer Detection Breast Tomosynthesis Breast Density Density Assessment Software Technology Artificial Intelligence
3_Steps_to_Improve_Your_Overall_Breast_Health_1.jpg

iCAD Named 2018 MedTech Breakthrough Award Winner for PowerLook Tomo Detection

June 06, 2018
Category: iNFORMED - Blog

Last month we announced that our digital breast tomosynthesis (DBT) solution – PowerLook Tomo Detection – had been named a finalist for the 2018 Medical Design Excellence Awards (MDEA), the premier awards program for the MedTech industry. Today, we are thrilled to announce continued momentum and additional industry recognition.

 

iCAD has been selected as the winner of the 2018 MedTech Breakthrough Award in the Best New Technology Solution – Radiology category.


Each year the MedTech... Continue reading

Tags: 3D Mammography Breast Cancer Detection Breast Tomosynthesis Software Technology Artificial Intelligence
MedTech_Logo.jpg

iCAD Named 2018 MedTech Breakthrough Award Winner

June 06, 2018
Category: Press Releases

Company’s PowerLook® Tomo Detection Solution Recognized as “Best New Radiology Solution” 


Nashua, NH – June 6, 2018 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its PowerLook® Tomo Detection solution has been selected as the winner of the “Best New Radiology Solution” award by MedTech Breakthrough, an independent organization recognizing the top companies, technologies and... Continue reading

5 Ways to Protect Yourself and Your Breast Health

May 17, 2018
Category: iNFORMED - Blog

May 13-19 is National Women’s Health Week and a great opportunity for women to stop, take a breather and remember that putting your own health first will allow you to take better care of your family and loved ones.

This includes staying on top of your breast health.


With about 1 in 8 women in the U.S. being diagnosed with breast cancer in her lifetime, it is the most commonly diagnosed cancer in women. On average, every 2 minutes a woman is diagnosed with breast cancer and 1 woman will die of breast cancer... Continue reading

Tags: 3D Mammography Breast Cancer Detection Breast Tomosynthesis Breast Density Density Assessment Software Technology Artificial Intelligence
5_Ways_to_Protect_Yourself_and_Your_Breast_Health_1.jpg

iCAD Reports First Quarter 2018 Financial Results

May 14, 2018
Category: Press Releases

Company Expects to Submit PowerLook Tomo Detection Version 2.0 for FDA Approval Shortly

Submission to be Based on Promising Results from Pivotal Clinical Reader Study


Conference call today at 4:30 p.m. ET

 

NASHUA, N.... Continue reading

iCAD To Report First Quarter 2018 Financial Results on Monday, May 14, 2018

May 08, 2018
Category: Press Releases

NASHUA, N.H. (May 8, 2018) – iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that it will release financial results for the first quarter ended March 31, 2018 after the close of the market, and host a conference call at 4:30 pm Eastern Time, on Monday, May 14, 2018.



Monday, May 14th @ 4:30pm Eastern Time

Domestic:

(800... Continue reading

Tags: Investors Related

iCAD Announced a Finalist for the 2018 Design Excellence Awards

May 01, 2018
Category: iNFORMED - Blog

In March of 2017, we announced that our deep learning based digital breast tomosynthesis (DBT) solution – PowerLook Tomo Detection – had received approval from the U.S. Food and Drug Administration (FDA). For those not familiar, PowerLook Tomo Detection is a first-of-its-kind, concurrent-read computer aided detection solution designed to assist radiologists in reading DBT studies. As part of the development for the product, PowerLook Tomo went through a reader study where it showed time savings of 29.2% for a radiologist when reading large data sets without impacting radiolog... Continue reading

Tags: 3D Mammography Breast Cancer Detection Breast Tomosynthesis Software Technology Artificial Intelligence
1 Comment
Finalist_for_the_2018_Design_Excellence_Awards.jpg

iCAD Announces Presentation of Positive Clinical Data on Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers at ESTRO 37

April 19, 2018
Category: Press Releases

Company to showcase advanced, multi-platform electronic brachytherapy (eBx) technology in booth 6800

Nashua, N.H. and Barcelona, Spain (ESTRO Booth 6800) (April 19, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that researchers from Hospital Universitario Miguel Servet in Zaragoza, Spain will present new results from three clinical... Continue reading

iCAD Reports Fourth Quarter And Full-Year 2017 Financial Results

March 22, 2018
Category: Press Releases

Fourth quarter total revenues increased 14% year-over-year; total revenues increased 22% excluding MRI asset sale


Conference call today at 4:30 p.m. ET


NASHUA, N.H. (March 22, 2018) – iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2017.


View Webcast
Full Results

Continue reading

Breast Density and Breast Cancer: What’s the Connection?

March 22, 2018
Category: iNFORMED - Blog

Has your healthcare provider ever spoken with you about breast density? Are you aware of the correlation between breast density and breast cancer? If you answered no to either of these questions, we urge you to keep reading.

 

Research has shown that women with dense breasts can be six times more likely to develop breast cancer; but what exactly does having dense breasts mean, and what can you do if you are one of the more than 40 percent of women in the U.S. with dense breast tissue?

 

For starters, having dense breasts simply means you... Continue reading

Tags: Breast Cancer Detection Breast Density Density Assessment Software Technology
iStock-611318594_small.jpg

CONNECT

© 2018, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo and PowerLook are a trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.